Performance of galactomannan, beta-d-glucan, aspergillus lateral-flow device, conventional culture, and pcr tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis

Journal of Clinical Microbiology

Volumn 52, Issue 6, 2014, Pages 2039-2045

  Hoenigl, M ^a   Prattes, J ^a   Spiess, B ^b   Wagner, J ^a   Prueller, F ^a   Raggam, R B ^a   Posch, V ^a   Duettmann, W ^a   Hoenigl, K ^a   Wolfler A ^a   Koidl, C ^a   Buzina, V ^a   Reinwald, M ^b   Thornton, C R ^c   Krause, R ^a   Buchheidt, D ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF EXETER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCAN; GALACTOMANNAN; FUNGAL DNA; FUNGUS ANTIGEN; GLUCAN; MANNAN;

ADULT; AGED; ARTICLE; AUSTRIA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FUNGUS CULTURE; GERMANY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOCOMPROMISED PATIENT; INTERMETHOD COMPARISON; LATERAL FLOW DEVICE TEST; LUNG ASPERGILLOSIS; LUNG FLUID; MAJOR CLINICAL STUDY; MALE; POINT OF CARE TESTING; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UNIVERSITY HOSPITAL; ASPERGILLUS; BRONCHOALVEOLAR LAVAGE FLUID; CHEMISTRY; COMPARATIVE STUDY; EVALUATION STUDY; GROWTH, DEVELOPMENT AND AGING; IMMUNOCOMPROMIZED PATIENT; INVASIVE PULMONARY ASPERGILLOSIS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; YOUNG ADULT;

ADULT; AGED; ANTIGENS, FUNGAL; ASPERGILLUS; AUSTRIA; BRONCHOALVEOLAR LAVAGE FLUID; DNA, FUNGAL; FEMALE; GERMANY; GLUCANS; HOSPITALS, UNIVERSITY; HUMANS; IMMUNOCHROMATOGRAPHY; IMMUNOCOMPROMISED HOST; INVASIVE PULMONARY ASPERGILLOSIS; MALE; MANNANS; MICROBIOLOGICAL TECHNIQUES; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84901652680     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00467-14     Document Type: Article

References (54)

1. Kontoyiannis DP, Marr KA, Park BJ, Alexander BD, Anaissie EJ, Walsh TJ, Ito J, Andes DR, Baddley JW, Brown JM, Brumble LM, Freifeld AG, Hadley S, Herwaldt LA, Kauffman CA, Knapp K, Lyon GM, Morrison VA, Papanicolaou G, Patterson TF, Perl TM, Schuster MG, Walker R, Wannemuehler KA, Wingard JR, Chiller TM, Pappas PG. 2010. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin. Infect. Dis. 50:1091-1100. http://dx.doi.org/10.1086/651263.
2. Hoenigl M, Salzer HJ, Raggam RB, Valentin T, Rohn A, Woelfler A, Seeber K, Linkesch W, Krause R. 2012. Impact of galactomannan testing on the prevalence of invasive aspergillosis in patients with hematological malignancies. Med. Mycol. 50:266-269. http://dx.doi.org/10.3109/13693786.2011.603102.
3. Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, Kontoyiannis DP, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Perl TM, Oster RA, Schuster MG, Walker R, Walsh TJ, Wannemuehler KA, Chiller TM. 2010. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin. Infect. Dis. 50:1101-1111. http://dx.doi.org/10.1086/651262.
4. Perkhofer S, Lass-Fl?rl C, Hell M, Russ G, Krause R, H?nigl M, Geltner C, Auberger J, Gastl G, Mitterbauer M, Willinger B, Kn?bl P, Resch G, Waldner R, Makrai A, Hartmann G, Girschikofsky M, Greil R. 2010. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients. Int. J. Antimicrob. Agents 36:531-536. http://dx.doi.org/10.1016/j.ijantimicag.2010.08.010.
5. Hoenigl M, Zollner-Schwetz I, Sill H, Linkesch W, Lass-Fl?rl C, Schnedl WJ, Krause R. 2011. Epidemiology of invasive fungal infections and rationale for antifungal therapy in patients with haematological malignancies. Mycoses 54:454-459. http://dx.doi.org/10.1111/j.1439-0507.2010.01881.x.
6. Shannon VR, Andersson BS, Lei X, Champlin RE, Kontoyiannis DP. 2010. Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant. 45:647-655. http://dx.doi.org/10.1038/bmt.2009.203.
7. Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, Wingard JR, Herbrecht R, Ribaud P, Patterson TF, Troke PF, Denning DW, Bennett JE, de Pauw BE, Rubin RH. 2007. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin. Infect. Dis. 44:373-379. http://dx.doi.org/10.1086/509917. (Pubitemid 46147619)
8. Lass-Fl?rl C, Resch G, Nachbaur D, Mayr A, Gastl G, Auberger J, Bialek R, Freund MC. 2007. The value of computed tomography-guided percutaneous lung biopsy for diagnosis of invasive fungal infection in immunocompromised patients. Clin. Infect. Dis. 45:e101-e104. http://dx.doi.org/10.1086/521245. (Pubitemid 47580399)
9. Hoenigl M, Duettmann W, Raggam RB, Seeber K, Troppan K, Fruhwald S, Prueller F, Wagner J, Valentin T, Zollner-Schwetz I, W?lfler A, Krause R. 2013. Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies. Antimicrob. Agents Chemother. 57:3262-3267. http://dx.doi.org/10.1128/AAC.00251-13.
10. Chamilos G, Luna M, Lewis RE, Bodey GP, Chemaly R, Tarrand JJ, Safdar A, Raad II, Kontoyiannis DP. 2006. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 91: 986-989. (Pubitemid 44023159)
11. Sink? J, Csomor J, Nikolova R, Lueff S, Kriv?n G, Rem?nyi P, B?tai A, Masszi T. 2008. Invasive fungal disease in allogeneic hematopoietic stem cell transplant recipients: an autopsy-driven survey. Transpl. Infect. Dis. 10:106-109. http://dx.doi.org/10.1111/j.1399-3062.2007.00264.x. (Pubitemid 351393087)
12. Hoenigl M, Valentin T, Salzer HJ, Zollner-Schwetz I, Krause R. 2010. Underestimating the real burden of invasive fungal infections in hematopoietic stem cell transplant recipients? Clin. Infect. Dis. 51:253-254, author reply 254-255. http://dx.doi.org/10.1086/653684.
13. Seeber K, Duettmann W, Krause R, Hoenigl M. 2012. Usefulness of the serum galactomannan assay for early response assessment and treatment stratifications of invasive aspergillosis. Curr. Fungal Infect. Rep. 6:198-205. http://dx.doi.org/10.1007/s12281-012-0099-5.
14. Husain S, Clancy CJ, Nguyen MH, Swartzentruber S, Leather H, LeMonte AM, Durkin MM, Knox KS, Hage CA, Bentsen C, Singh N, Wingard JR, Wheat LJ. 2008. Performance characteristics of the platelia Aspergillus enzyme immunoassay for detection of Aspergillus galactomannan antigen in bronchoalveolar lavage fluid. Clin. Vaccine Immunol. 15: 1760-1763. http://dx.doi.org/10.1128/CVI.00226-08.
15. Gerlinger MP, Rousselot P, Rigaudeau S, Billon C, Touratier S, Castaigne S, Eloy O. 2012. False-positive galactomannan Platelia due to piperacillin-tazobactam. Med. Mal. Infect. 42:10-14. http://dx.doi.org/10.1016/ j.medmal.2011.10.018.
16. Mikulska M, Furfaro E, Del Bono V, Raiola AM, Ratto S, Bacigalupo A, Viscoli C. 2012. Piperacillin/tazobactam (Tazocin) seems to be no longer responsible for false-positive results of the galactomannan assay. J. Antimicrob. Chemother. 67:1746-1748. http://dx.doi.org/10.1093/jac/dks111.
17. Patterson TF. 2009. Risk stratification for invasive aspergillosis: early assessment of host susceptibility. Med. Mycol. 47(Suppl 1):S255-S260. http://dx.doi.org/10.1080/13693780902718339.
18. Marr KA, Laverdiere M, Gugel A, Leisenring W. 2005. Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay. Clin. Infect. Dis. 40:1762-1769. http://dx.doi.org/10.1086/429921. (Pubitemid 40799945)
19. Hoenigl M, Raggam RB, Salzer HJ, Valentin T, Valentin A, Zollner-Schwetz I, Strohmeier AT, Seeber K, W?lfler A, Sill H, Krause R. 2012. Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies. Int. J. Antimicrob. Agents 39: 510-513. http://dx.doi.org/10.1016/j.ijantimicag.2012.02.002.
20. Hoenigl M, Seeber K, Koidl C, Buzina W, W?lfler A, Duettmann W, Wagner J, Strenger V, Krause R. 2013. Sensitivity of galactomannan enzyme immunoassay for diagnosing breakthrough invasive aspergillosis under antifungal prophylaxis and empirical therapy. Mycoses 56:471-476. http://dx.doi.org/10.1111/myc.12060.
21. De Vlieger G, Lagrou K, Maertens J, Verbeken E, Meersseman W, Van Wijngaerden E. 2011. Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study. J. Clin. Microbiol. 49:3783-3787. http://dx.doi.org/10.1128/JCM.00879-11.
22. Eggimann P, Marchetti O. 2011. Is (1?3)-D-glucan the missing link from bedside assessment to pre-emptive therapy of invasive candidiasis? Crit. Care 15:1017. http://dx.doi.org/10.1186/cc10544.
23. Heyland D, Jiang X, Day AG, Laverdiere M. 2011. Serum beta-D-glucan of critically ill patients with suspected ventilator-associated pneumonia: preliminary observations. J. Crit. Care 26:536.e1-536.e9. http://dx.doi.org/10. 1016/j.jcrc.2011.01.002.
24. Lamoth F, Cruciani M, Mengoli C, Castagnola E, Lortholary O, Richardson M, Marchetti O, Third European Conference on Infections in Leukemia (ECIL-3). 2012. Beta-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3). Clin. Infect. Dis. 54:633-643. http://dx.doi.org/10.1093/ cid/cir897.
25. Bassetti M, Mikulska M, Viscoli C. 2010. Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit. Crit. Care 14:244. http://dx.doi.org/10.1186/cc9239.
26. Marchetti O, Lamoth F, Mikulska M, Viscoli C, Verweij P, Bretagne S, European Conference on Infections in Leukemia (ECIL) Laboratory Working Groups. 2012. ECIL recommendations for the use of biological markers for the diagnosis of invasive fungal diseases in leukemic patients and hematopoietic SCT recipients. Bone Marrow Transplant. 47:846-854. http://dx.doi.org/10.1038/bmt. 2011.178.
27. Posteraro B, De Pascale G, Tumbarello M, Torelli R, Pennisi MA, Bello G, Maviglia R, Fadda G, Sanguinetti M, Antonelli M. 2011. Early diagnosis of candidemia in intensive care unit patients with sepsis: a prospective comparison of (1?3)-D-glucan assay, Candida score, and colonization index. Crit. Care 15:R249. http://dx.doi.org/10.1186/cc10507.
28. Pliyev BK. 2009. Activated human neutrophils rapidly release the chemotactically active D2D3 form of the urokinase-type plasminogen activator receptor (uPAR/CD87). Mol. Cell. Biochem. 321:111-122. http://dx.doi.org/10. 1007/s11010-008-9925-z.
29. Theel ES, Jespersen DJ, Iqbal S, Bestrom JE, Rollins LO, Misner LJ, Markley BJ, Mandrekar J, Baddour LM, Limper AH, Wengenack NL, Binnicker MJ. 2013. Detection of (1, 3)-beta-D-glucan in bronchoalveolar lavage and serum samples collected from immunocompromised hosts. Mycopathologia 175:33-41. http://dx.doi.org/10.1007/s11046-012-9579-y.
30. Thornton C, Johnson G, Agrawal S. 2012. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology. J. Vis. Exp. (61):pii:3721. http://dx.doi.org/10.3791/3721.
31. Thornton CR. 2008. Development of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis. Clin. Vaccine Immunol. 15:1095-1105. http://dx.doi.org/10.1128/CVI.00068-08. (Pubitemid 352018323)
32. Wiederhold NP, Thornton CR, Najvar LK, Kirkpatrick WR, Bocanegra R, Patterson TF. 2009. Comparison of lateral flow technology and galactomannan and (1?3)-D-glucan assays for detection of invasive pulmonary aspergillosis. Clin. Vaccine Immunol. 16:1844-1846. http://dx.doi.org/10.1128/CVI.00268-09.
33. Hoenigl M, Koidl C, Duettmann W, Seeber K, Wagner J, Buzina W, W?lfler A, Raggam RB, Thornton CR, Krause R. 2012. Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients. J. Infect. 65:588-591. http://dx.doi.org/10.1016/j.jinf.2012.10.003.
34. Reinwald M, Spiess B, Heinz WJ, Heussel CP, Bertz H, Cornely OA, Hahn J, Lehrnbecher T, Kiehl M, Laws HJ, Wolf HH, Schwerdtfeger R, Schultheis B, Burchardt A, Klein M, D?rken M, Claus B, Schlegel F, Hummel M, Hofmann WK, Buchheidt D. 2013. Aspergillus PCR-based investigation of fresh tissue and effusion samples in patients with suspected invasive aspergillosis enhances diagnostic capabilities. J. Clin. Microbiol. 51:4178-4185. http://dx.doi.org/10. 1128/JCM.02387-13.
35. Reichard U, Buchheidt D, Lass-Fl?rl C, Loeffler J, Lugert R, Ruhnke M, Tintelnot K, Weig M, Gross U. 2012. Interlaboratory comparison of PCR-based identification of Candida and AspergillusDNAin spiked blood samples. Mycoses 55:426-434. http://dx.doi.org/10.1111/j.1439-0507.2011.02167.x.
36. Reinwald M, Hummel M, Kovalevskaya E, Spiess B, Heinz WJ, Vehreschild JJ, Schultheis B, Krause SW, Claus B, Suedhoff T, Schwerdtfeger R, Reuter S, Kiehl MG, Hofmann WK, Buchheidt D. 2012. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies. J. Antimicrob. Chemother. 67: 2260-2267. http://dx.doi.org/10.1093/jac/dks208.
37. White PL, Parr C, Thornton C, Barnes RA. 2013. Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis. J. Clin. Microbiol. 51:1510-1516. http://dx.doi.org/10.1128/JCM.03189-12.
38. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, Pappas PG, Maertens J, Lortholary O, Kauffman CA, Denning DW, Patterson TF, Maschmeyer G, Bille J, Dismukes WE, Herbrecht R, Hope WW, Kibbler CC, Kullberg BJ, Marr KA, Mu?oz P, Odds FC, Perfect JR, Restrepo A, Ruhnke M, Segal BH, Sobel JD, Sorrell TC, Viscoli C, Wingard JR, Zaoutis T, Bennett JE, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group, National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. 2008. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin. Infect. Dis. 46:1813-1821. http://dx.doi.org/10.1086/588660.
39. White PL, Bretagne S, Klingspor L, Melchers WJ, McCulloch E, Schulz B, Finnstrom N, Mengoli C, Barnes RA, Donnelly JP, Loeffler J, European Aspergillus PCR Initiative. 2010. Aspergillus PCR: one step closer to standardization. J. Clin. Microbiol. 48:1231-1240. http://dx.doi.org/10.1128/JCM.01767-09.
40. Hoenigl M, Strenger V, Buzina W, Valentin T, Koidl C, W?lfler A, Seeber K, Valentin A, Strohmeier AT, Zollner-Schwetz I, Raggam RB, Urban C, Lass-Fl?rl C, Linkesch W, Krause R. 2012. European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies. J. Antimicrob. Chemother. 67:2029-2033. http://dx.doi.org/10.1093/jac/dks155.
41. Wiederhold NP, Najvar LK, Bocanegra R, Kirkpatrick WR, Patterson TF, Thornton CR. 2013. Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis. J. Clin. Microbiol. 51:459-465. http://dx.doi.org/10. 1128/JCM.02142-12.
42. Pr?ller F, Wagner J, Raggam RB, Hoenigl M, Kessler HH, Truschnig-Wilders M, Krause R. 2014. Automation of serum (1-3)-beta-D-glucan testing allows reliable and rapid discrimination of patients with and without candidemia. Med. Mycol., in press.
43. Skladny H, Buchheidt D, Baust C, Krieg-Schneider F, Seifarth W, Leib-M?sch C, Hehlmann R. 1999. Specific detection of Aspergillus species in blood and bronchoalveolar lavage samples of immunocompromised patients by two-step PCR. J. Clin. Microbiol. 37:3865-3871.
44. D?Haese J, Theunissen K, Vermeulen E, Schoemans H, De Vlieger G, Lammertijn L, Meersseman P, Meersseman W, Lagrou K, Maertens J. 2012. Detection of galactomannan in bronchoalveolar lavage fluid samples of patients at risk for invasive pulmonary aspergillosis: analytical and clinical validity. J. Clin. Microbiol. 50:1258-1263. http://dx.doi.org/10.1128/JCM.06423-11.
45. Maertens J, Maertens V, Theunissen K, Meersseman W, Meersseman P, Meers S, Verbeken E, Verhoef G, Van Eldere J, Lagrou K. 2009. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin. Infect. Dis. 49:1688-1693. http://dx.doi.org/10.1086/647935.
46. Reinwald M, Spiess B, Heinz WJ, Vehreschild JJ, Lass-Fl?rl C, Kiehl M, Schultheis B, Krause SW, Wolf HH, Bertz H, Maschmeyer G, Hofmann WK, Buchheidt D. 2012. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples. Eur. J. Haematol. 89:120-127. http://dx.doi.org/10.1111/j.1600-0609.2012.01806.x.
47. Torelli R, Sanguinetti M, Moody A, Pagano L, Caira M, De Carolis E, Fuso L, De Pascale G, Bello G, Antonelli M, Fadda G, Posteraro B. 2011. Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from highrisk patients compared to a galactomannan enzyme immunoassay. J. Clin. Microbiol. 49:4273-4278. http://dx.doi.org/10.1128/JCM.05026-11.
48. Guo YL, Chen YQ, Wang K, Qin SM, Wu C, Kong JL. 2010. Accuracy of BAL galactomannan in diagnosing invasive aspergillosis: a bivariate metaanalysis and systematic review. Chest 138:817-824. http://dx.doi.org/10.1378/chest.10-0488.
49. Buchheidt D, Baust C, Skladny H, Ritter J, Suedhoff T, Baldus M, Seifarth W, Leib-Moesch C, Hehlmann R. 2001. Detection of Aspergillus species in blood and bronchoalveolar lavage samples from immunocompromised patients by means of 2-step polymerase chain reaction: clinical results. Clin. Infect. Dis. 33:428-435. http://dx.doi.org/10.1086/321887. (Pubitemid 32709572)
50. Buchheidt D, Baust C, Skladny H, Baldus M, Br?uninger S, Hehlmann R. 2002. Clinical evaluation of a polymerase chain reaction assay to detect Aspergillus species in bronchoalveolar lavage samples of neutropenic patients. Br. J. Haematol. 116:803-811. http://dx.doi.org/10.1046/j.0007-1048.2002.03337. x. (Pubitemid 34226999)
51. Held J, Schmidt T, Thornton CR, Kotter E, Bertz H. 2013. Comparison of a novel Aspergillus lateral-flow device and the Platelia galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation. Infection 41:1163-1169. http://dx.doi.org/10.1007/s15010-013- 0472-5.
52. Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP, Francais A, Martin C, Guidet B, Timsit JF. 2012. Systemic antifungal therapy in critically ill patients without invasive fungal infection. Crit. Care Med. 40:813-822. http://dx.doi.org/10.1097/CCM.0b013e318236f297.
53. Morrissey CO, Chen SC, Sorrell TC, Milliken S, Bardy PG, Bradstock KF, Szer J, Halliday CL, Gilroy NM, Moore J, Schwarer AP, Guy S, Bajel A, Tramontana AR, Spelman T, Slavin MA, Australasian Leukaemia Lymphoma Group and the Australia and New Zealand Mycology Interest Group. 2013. Galactomannan and PCR versus culture and histology for directing use of antifungal treatment for invasive aspergillosis in high-risk haematology patients: a randomised controlled trial. Lancet Infect. Dis. 13:519-528. http://dx.doi.org/10.1016/ S1473-3099(13)70076-8.
54. Karageorgopoulos DE, Vouloumanou EK, Ntziora F, Michalopoulos A, Rafailidis PI, Falagas ME. 2011.-D-glucan assay for the diagnosis of invasive fungal infections: a meta-analysis. Clin. Infect. Dis. 52:750-770. http://dx.doi.org/10.1093/cid/ciq206.